BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G951. A total of 5 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,000 | -66.7% | 14,200 | +17.4% | 0.00% | -66.7% |
| Q1 2020 | $15,000 | -89.3% | 12,100 | -80.8% | 0.01% | -86.8% |
| Q4 2019 | $140,000 | +79.5% | 63,000 | +133.3% | 0.07% | +54.5% |
| Q3 2019 | $78,000 | +1460.0% | 27,000 | +28.0% | 0.04% | +1366.7% |
| Q2 2019 | $5,000 | -90.9% | 21,100 | +219.2% | 0.00% | -90.3% |
| Q1 2019 | $55,000 | – | 6,611 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 194,500 | $16,488,000 | 0.03% |
| SIMPLEX TRADING, LLC | 65,000 | $5,510,000 | 0.01% |
| JANE STREET GROUP, LLC | 121,100 | $10,266,000 | 0.00% |
| Worth Venture Partners, LLC | 14,200 | $5,000 | 0.00% |
| IMC-Chicago, LLC | 18,000 | $1,526,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |